Friday, December 9, 2011, 5:00am CST
The urgent care market is heating up. The largest company in the industry in Middle Tennessee, Tennessee Urgent Care Associates, was recently purchased by a California-based company, while another large national operator, Jacksonville-based Solantic, has opened a corporate office here that could become the firm’s headquarters. On top of that, smaller but growing companies have recently opened or plan to open local urgent care centers. By the end of 2012, there could be at least six new clinics that would have opened in the Nashville area over a two-year period.
Industry observers say interest in urgent care is on the rise as consumers become increasingly frustrated with long waits — both in the emergency room and for primary care appointments. According to the Urgent Care Association of America, there are approximately 8,700 urgent care centers in the U.S. The number of centers grew by 330 from 2008 to 2009, and by 304 from 2009 to 2010.
“There is a lot of growth in Tennessee right now and some big players are moving in there, so it’s a very active area from an industry standpoint,” said Lou Ellen Horwitz , executive director of Urgent Care Association of America. Urgent care provides walk-in, extended-hour access for illness and injuries either beyond the scope or availability of the typical primary care practice. “Nashville is certainly following the pattern of national growth in urgent care,” said Robert Cranfield , regional medical director for U.S. Healthworks and former president of Tennessee Urgent Care Associates. U.S. Healthworks is the second-largest urgent care operator in the U.S. with 171 clinics, according to UCAA statistics. The Valencia, Calif.-based company acquired 11 Middle Tennessee medical centers with the acquisition in October of TUCA, marking its first foray into Tennessee. Cranfield said local operations will remain the same as U.S. Healthworks ratchets up marketing efforts. The TUCA brand name will phase out by the end of the year.
Meanwhile, startup company NeighborMD Urgent Care has two centers in the area — Hermitage and Brentwood — after being founded less than two years ago by a management team that includes former O’Charley’s Chairman and CEO Greg Burns . “People don’t want to go to an emergency room unless it’s life-threatening,” Burns said. “People care about their health care experience. It’s more than just waiting for a physician.” NeighborMD, which raised $1.5 million in a first round of funding and is currently raising capital in a second round, plans to open two more clinics in the area in early 2012 and have five total by this time next year.
Growth on the horizon
Recent studies have found that the average cost of an urgent care visit is slightly below the average primary care visit, $155 versus $165, according to data compiled by Nashville-based Plutus Capital Partners. Moreover, the role of the typical primary care physician is expected to expand in the future, leaving them with two options — extend their office hours and take in additional patients, or partner with urgent care centers to handle episodic visits.
“If you look at other industries that have consolidated rapidly, then you can really see urgent care taking off,” said Gordon Maner , managing partner for Plutus Capital Partners. “People aren’t signing up for primary care, and the primary care doctors are getting older.” Maner said there are several factors contributing to the interest and growth in urgent care, including: additional coverage provided through health reform; hospitals increasingly looking for ways to better coordinate care with specialists, physician groups and other providers; and managed care companies attempting to lower costs.
Cranfield said teaming with U.S. Healthworks made sense as it broadens TUCA’S “power of national purchasing.” “Ultimately, this will make us a stronger organization,” Cranfield said. “There’s been a move for several years to consolidate urgent care, and we’ve been looking at it for some time.” Said Maner, “There’s a pretty unbelievable growth opportunity, due to the converging tailwinds in urgent care.”
Spirited competition
Solantic opened a new office in Brentwood on Nov. 28, and company CEO Michael Klein and other C-level executives work there. Paul Dickison, vice president of marketing for Solantic, said the company is in the process of developing its business plan for 2012 and that new urgent care centers will likely be announced in the fourth quarter. Solantic operates 32 clinics across the country. Although the company hasn’t committed to opening any clinics in Nashville, observers feel it will eventually.
“I would be incredibly surprised if they didn’t make their presence felt here in Nashville, and in Tennessee in general,” Maner said. Other out-of-state companies involved include Hoover, Ala.-based American Family Care, which opened a clinic in Smyrna in late September, its second urgent care location in the area. Burns said competition can be healthy, but only up to a point. “Just as long as we don’t cannibalize ourselves,” Burns said. “There’s only so many people who get sick.”
Steve Samudrala , medical director of Nashville-based America’s Family Doctors, said he’s seen a sharp decrease in walk-in appointments over the past five years, which he attributes largely to an increase in urgent care centers. Walk-ins for America’s Family Doctors — which has three clinics in the area — have dropped from about 80 percent of customers in 2006 to roughly 30 percent now, Samudrala said. “It’s getting incendiary,” Samudrala said. “There seems to be an urgent care center on every corner.”
BOSTON and NEW YORK, Oct. 24, 2011 — CenterWatch and Plutus Capital Partners today announce the launch of Clinical Trials Quarterly, a co-branded newsletter for the contract research organization (CRO) industry that expands CenterWatch’s reach to financial clients in Asia and Europe.
The quarterly newsletter, with an initial distribution base of over 700, covers CROs, with a particular focus on the financial and business aspects of the industry.
Each issue will feature an M&A Tracker of all of the quarter’s biggest CRO mergers and acquisitions, a recap of the quarter’s CRO strategic partnerships, top headlines and news on R&D trends. It also will include interviews with industry insiders and a look at top pharmaceutical and biotechnology company drug development pipelines.
"This partnership leverages Plutus' deal experience and network in the CRO space, with CenterWatch's industry insights, so as to provide companies with access to information that can guide their strategic objectives," said Ripun Jai Mehta, Managing Partner, Plutus Capital Partners.
"This strategic collaborative partnership with Plutus Capital provides us the opportunity to share clinical trials content with the financial community in Asia and Europe, who are tracking all activity within the industry,” said Joan Chambers, Chief Operating Officer of CenterWatch. “In a time of increased M&As and strategic partnerships, it's important to keep all industry stakeholders well informed—this collaboration provides that opportunity for Plutus Capital and CenterWatch."
For subscription information, visit www.plutuscp.com/ctq.
About Plutus Capital Partners
Plutus Capital Partners is a New York-based boutique advisory firm that provides investment-banking services, including M&A, private placement and drug licensing, to the global healthcare and life sciences industry. Plutus assists global CROs with their growth, acquisition and exit strategies.
www.plutuscp.com.
About CenterWatch
Founded in 1994, CenterWatch is a trusted source and global destination of clinical trials information for both professionals and patients. CenterWatch provides a wide variety of information services including grant leads for investigative sites; business development leads for contract service providers; postings of career opportunities; listings of clinical trials actively seeking patients; advertising and promotional opportunities; and proprietary business analysis and data about the global clinical trials industry. Visit
www.centerwatch.com.
New York, November 1st 2010 - Plutus Capital Partners LLC, through its relationship with Allen Mooney & Barnes Brokerage Services, LLC, announced today the sale of Urgent Cares of America, Inc. ('UCA') and its affiliates to The Comvest Group.
Urgent Cares of America is a North Carolina-based owner and operator of urgent care facilities focusing on the delivery of non-appointment based medicine to the non-emergency patient market. In partnership with physicians and other healthcare professionals, the Company is currently the owner of nine operating centers with a primary concentration in the Raleigh metropolitan area. The centers are open 358 days a year and are staffed with experienced and licensed Physicians, Physician Assistants and Nurse Practitioners. UCA was founded by Jason Williams and Cameron Perkins, two Physician Assistants, who believe healthcare can be most effectively delivered when patients are seen in a timely and cost-effective manner. They have been striving to create this patient-centric environment since the firm's founding in 2001.
Comvest operating partner, John Randazzo, former CEO of Healthcare Innovations and founder of Value Health, will join UCA as CEO. Additionally, Chuck Saunders, M.D., former Chief Medical Officer of Healtheon/WebMD, will also join the UCA board as Chairman.
About Plutus
Plutus Capital Partners is a boutique advisory firm that provides investment banking services globally. Plutus partners with business owners and management teams to provide capital and advisory services throughout all stages of a firm's life.
By taking an industry-specific and geographically-strategic focus, Plutus is positioned to provide a unique perspective while supporting clients with investment banking services on capital raises, and advisory services on mergers, acquisitions, divestitures, licensings, and other strategic transactions. The Plutus professionals focus on growth companies across their specific areas of expertise including healthcare, technology, business process outsourcing, and financial services.
The firm was founded on the belief that an opportunity exists in the financial services market for a company to align itself with clients rather than merely focus on one-off transactions. Plutus maintains a standard of excellence with hands-on participation by a dynamic team in all projects it undertakes.
New York, September 22nd, 2009 – Plutus Capital Partners LLC, a leading merchant banking firm focused on partnering with business owners and management teams to provide capital and advisory services throughout all stages of a firm's life, announced that they were advisor to FAIM Investments LLC (FAIM), in the acquisition of substantially all of the assets of Eastover Capital Management.
Eastover Investment Advisors, LLC, is a new company formed for the purpose of acquiring the assets of Eastover Capital Management, LLC, and is owned by a consortium of private equity shareholders and FAIM Investments, LLC. Plutus Capital Partners LLC acted as the exclusive financial advisor to FAIM on the transaction.
Transaction Summary:
September 2009
Client: FAIM Investments, LLC
Deal: Acquisition of Eastover Capital Management
Industry: Asset Management
Role: Exclusive Financial Advisor
New York, March 3rd, 2009 - Plutus Capital Partners LLC, a leading merchant banking firm focused on partnering with business owners and management teams to provide capital and advisory services throughout all stages of a firm's life, announced today that Mark Padgett would be joining the firm as a partner focused on the healthcare sector with emphasis on cross-border relationships, primarily between Latin America and India.
Mr. Padgett was previously and investment banker with Susquehanna International Group, LLLP in their healthcare group. Mr. Padgett's previous experience in the healthcare industry includes conducting biomedical research for the Medical University of South Carolina's Department of Medicine where he co-authored multiple publications that were published in the Journal of Endocrinology and working for Janssen-Cilag Pharmaceuticals (Johnson & Johnson) in New Business Development in Mexico City, Mexico. On Wall Street, Mr. Padgett conducted sell-side research at Buckingham Research Group and Key Bank and was a buy-side analyst at Natexis Banque Populaires.
Gordon A. Maner, Managing Partner of Plutus said “ with the recruitment of Mark, Plutus is well positioned to offer first-class advice to companies interested in strategic initiatives like licensing opportunities or merger or acquisitions between the U.S., India, and Latin America. These sectors are underserved, and will provide Plutus with an outstanding opportunity to gain market share and better serve our clients.